-
-
7 . Academic Journal
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
- 저자
- by De Bleecker, Jan L.; De Koning, Kathy; De Mey, Katrien; De Pue, Annelien; Mercelis, Rudolf, et al.
- 소스
- In The Lancet Neurology July 2021 20(7):526-536